Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

182 Syringe *TBW

12th World AIDS Conference

- Keyword Abstract -
ong IDU recruited at 11 syringe exchange programmes in Canada 23172
cipants of a van-based exchange toward pharmacy-base 23173
ciated with needle and sharing by injecting drug users in 23199
) and non-prescription availability/Syringe source, re-us 23200
e association between exchange, drug use, and drug trea 33387
at is the current state of exchange in the UK? A national su 33392
ong users of the Seattle exchange/Reduction in injection ri 33400
od traces on their used syringes /The validation of statements by i 14114
econdary acquisition of given out by the Baltimore Needl 23170
/Recovery of HIV from /Recovery of HIV from 23222
ysical characteristics of turned in at the Baltimore Needle 23241
3 study (Protocol L1057 T- 31) of Panretin"T gel (LGD1057, ALRT10 619*/22283

e for infectivity assay of and M-tropic HIV-1, and its application to
strains that infect CD4+ T-cell lines, Molt4 and SupT1/Study of co-r
CR4 inhibitor that blocks line-tropic HIV-1 entry/A small mole
f protein induces CD4+ apoptosis through functional upregul
ation of a new long-term line SCHT persistently infected with
and is associated with functional defects/Peripheral expan
ssociated viremia-CD4 response/Extended benefit of prote
to viral load, and CD4+ count/The role of HIV-1 phenotype i
pid reconstitution of the receptor (TCR) repertoire following a
ulations/Human CD8+ differentiation in acute viral and chro
T + 3TC + indinavir) on function and apoptosis in early HIV in
diagnoses/Definition of lymphocyte inflection and prevalenc
and its relation to CD4 counts and disease progression in a
nfection/Limited CD4+ renewal as a mechanism for CD4 ly
-mediated disruption of homeostasis: Activation-mediated n
hages-mediated CD8+ killing via CXC-R4/ENV interactions
ophages/Stimulation of proliferation by TNF-a produced by
ne regimen/Protective mediated immunity induced by a con
her primary isolates or lines adapted strains expressed usin
ag-specific cytotoxic response in juvenile but not neonatal
es and antigen specific proliferation in HIV-2 exposed non-in
ypic characterisation of expansions in HIV infection/Phenoty
ment (HAART)/Specific responses in HIV-infected patients a
3 is required for specific cytotoxicity/New anti-HIV function:
els of specific cytotoxic (CTL) activity against HIV-1 proteins
own regulation of CD8+ expansions in HIV patients receiving
ce for increased CD4+ production in HIV-1 infection/Telom
s, UK/Idiopathic CD4+ lymphocytopenia (ICL): Experience i
w cytometry based CD4 enumeration for absolute and perce
nge in peripheral blood subset composition during asympto
rica/Normal values for subsets in the Free State region of S
ately predict the CD4+ count in a group of HIV-1-infected So
Changes in markers of differentiation and function during pr
he Amsterdam cohort/ renewal capacity in organ culture is d
er of both CD4 and CD8 T-cells in HIV-1 infection until end stage dis
n non-stimulated CD8+ from HIV infected patients/Increas
f primary human CD4+ /Effective pseudotyping of retroviral
bodies binding to CD4+ are a sensitive parameter to discrim
ed increase of cd45ra+ t-helper cells/Highly active antiretroviral th
s/Specific inhibition of T-lymphocyte- and macrophage-tropic HI
HIV-1 specific cytotoxic T-lymphocyte responses in uninfected Ke
parison between helper counts obtained by zymmu
nel for monitoring early responses in clinical trials/
stimation of peripheral subsets for HIV+ adults/Co
rease the replication of T-tropic HIV strains through CXCR4 stimul
onal antibodies/Role of HIV-1 V3 loop in viral entry into cel: Technical assistance ( TA ) for federally-funded HIV care planning
Iti-epitope polypeptide: TAB 9/Lymphocyte proliferative response
Iti-epitope polypeptide 9 adjuvated with montanide ISA720 is
arge with Erythromycin tablets, on Yaounde's sexually transmitted
chain reaction (PCR) in Taiwan /Rapid detection of HIV-1 subtype
pidemiology of HIV-1 in: Heterosexual males with HIV-1 E
ay and bisexual men in, Kaohsiung City, 1993-1997/Tren
event HIV/AIDS among Taiwanese college students/Predictors of
d drivers at Mamou and Tamagly stop sites (Guinea)/STD and HIV
d drivers at Mamou and stop sites (Guinea)/Prevention a
medical practitioners in Tamil Nadu, South India/Impact of training
ur and Thiruchengode, Nadu, India/Research on sex and se
allied groups in Salem, Nadu, India/HIV/AIDS awareness a
es in 10 cities/towns of Nadu/Male sexual health programm
nal Highway 7 at Hosur, Tamilnadu /Intervention among truck drive
port programme in rural Tanzania /Evaluation of an orphan support
n an urban hospital in during 1994-1996/The impact o
cers in Dar es Salaam, /Incidence of HIV-1 infection and
etic diversity of HIV-1 in: Use of heteroduplex mobility as
omen & blood donors in /Age specific change of serotype
Bukoba Urban, Kagera, /Decline in the prevalence and in
atally infected infants in /V3 of HIV-1 subtype C is over-re

41163
11111
11117
11145
11159
11220
341*/12101
12126
12185
12189
12200
13317
13327
270*/21103
21117
275*/21164
21168
549*/21198
21207
31129
605*/31133
31136
111*/31142
31148
31155
110*/31165
271 */31168
32151
41116
339*/41178
42185
42187
60649
60796
268*/21108
31171
41245
42110
32317
41182
600*/31123
42193
42206
60416
11119
60161
43527
21215
21216
22209
13146
13148
60206
14155
43322
43372
13475
14123
33250
60821
33107
12103
12423
13108
13110
13113
13114
13115

Keyword Abstract
mple of Dar es Salaam,: Results from the voluntary HIV c 13116
ties in Mwanza region, /Geographical variations in the p 13119
ontrol study in Mwanza, /Risk factors for seroconversion t 13282
guardian programme in /Protecting school girls against s 13533
I risk behaviour in rural /Antibody to Herpes simplex viru 14117
TIs and gender issues in /HIV/AIDS/STIs and gender issu 14216
evention and control in /Alternative IEC interventions for 14287
ir spouses in northwest /HIV incidence and HIV-associat 23152
cision on young girls in /The impact of obsolete tradition 23473
d testing in Kenya and: Results from the voluntary HIV c 24135
affected by HIV/AIDS in and how they are trying to surviv 24373
unselling and testing in and Kenya is cost-effective: Res 580*/33277
ence in Dar es Salaam, outreach programme/PLWHAs 33351
ntion project in northern /Community based HIV/High tra 33423
f a new IEC strategy for /Outlining of a new IEC strategy f 33471
me in primary schools in /Development of a district peer h 33522
enomenon in Mwanza, /AIDS stigma: A persistent social 417*/34159
and negative children in /Vitamin A supplements and mor 170*/42331
sentinel surveillance in relying on constantly submitted d 43462
s for HIV/AIDS/STDs in /The national strategic planning 43504
n rural Mwanza region,: A random sample survey/Preva 60682
ng adolescents in rural: Design of impact evaluation/Co 60993
orkplace settings - The Tanzanian experience/Using participatory 13456
n blood samples from adults/Evaluation of an experi 41155
of HIV-1 virus load by a TaqManT"-based product enhanced revers 41137
ion/Porphyria cutanea tarda: A controversial association with HIV 60883
ed we further spread it ( TASO experience)/United we prevent HIV/ 13406
S support organisation ( ) drama group to assist in the formati 23260
ulnerable children: The experience/Primary school educati 34267
ith special reference to /The role of community based progr 34342
ort organisation clinic - Mulago experience/Treating tuberc 60146
unction in HIV infection/ Taste and smell dysfunction in HIV infectio 42353
man monocytes/HIV-1 Tat protein promotes the synthesis of platel 21141
latory regions by HIV-1: Transactivation mechanisms of HPV-1 31223
s of exogenous Nef and proteins on HIV-1 infected or uninfecte 60872
cine Evaluation Group ( TAVEG ) in Thailand/Future planning for HI 33222
tro and its implications/ Taxonomy of the Hijda community in Mum 13430
se inhibitors/Activity of TaxotereTM (docetaxel) as therapy for pretr 60934
ry and extrapulmonary TB/AIDS patients/Cellular immune respon 31206
1 positive tuberculosis ( TB ) patients in the interior of C6te d'lvoire/ 11182
putum smear-negative suspects in a community with high HIV 12421
ncreasing frequency of among staff in a South African hospital: 611*/13246
linic/HIV/tuberculosis ( ) liaison nurse in the HIV clinic/HIV/tube 61*/13247
s drug users: The SerT/ study/Feasibility of screening and prev 13251
h risk" for tuberculosis ( )?/Which HIV infected populations sho 13252
diagnose tuberculosis ( ) infection/Lack of usefulness of anergy 13257
atural history of HIV and co-infection/Characteristics of HIV-infe 13260
land/HIV Infection and Associated with Injecting Drug Use and 616*/13264
actors for tuberculosis ( ) in a rural African population cohort with 13267
ms/Double trouble: HIV/ profiles from the US and the UK derived 13268
ts/Multidrugs resistant (MRTB): Study of an outbreak in HIV pa 615*/13274
ates among patients on treatment/Factors contributing to repor 13275
ulmonary tuberculosis ( ) on survival of HIV-infected Ugandan a 13315
ow 50/p l/Tuberculosis ( ) in HIV-infected patients with CD4 belo 22128
actors for tuberculosis ( ) in a cohort of HIV-infected patients in R 22132
91-1996/Tuberculosis ( ) in HIV-infected persons at an urban U 22135
uation of tuberculosis ( ) cases in AIDS patients in an out-patien 22139
hase of tuberculosis ( ) treatment in HIV-1 infected Ugandan a 454*/22140
ulmonary tuberculosis ( ) in a resource-poor setting with high HI 22146
fection in tuberculosis ( ) - Urban and rural experiences of differ 22152
ambia?/How likely are patients to be accurately diagnosed in u 453*"/22154
w cases of tuberculosis ( ) after the implementation of universal T 22155
herapy to tuberculosis ( ) in an out-patient clinic in Belo Horizont 22156
ase fatality rates of HIV/ in a semiurban community in southern 22159
Pattern of tuberculosis ( ) in HIV infected patients in Gujarat, Indi 22162
stitution/Tuberculosis ( ) - High risk factor in HIV infection evolu 22164
ulmonary tuberculosis ( ) associated with the HIV infection/Bron 22165
es of families living with and AIDS in East Hararghe and Harar, 24212
ucing anti-tuberculosis ( ) medication after Stevens-Johnson (SJ 32267
fight against HIV/AIDS/ in Cameroon/Experience press service 33499
on between in-hospital and PBP experience and quality of HIV- 42216
f HIV/AIDS, STDs, and: Results of a national study/Public heal 43405
HIV not associated with disease from recently acquired Mycoba 60415

h HIV and tuberculosis ( )/Directly observed therapy (DOT) of hi 60582
utility in the diagnosis of /Anergy testing: Questionable utility in t 60632
1 and HIV-2 co-infected patients before after TB treatment/Plas 60742
/Chemoprophylaxis for in HIV/AIDS, Mumbai/Chemoprophyla 60907

f vaccinia-env/gag/pol ( TBC-3B ) given by alternative routes, boost
ong young population of Tbilisi, Georgia/Condom use among youn
g on total body weight ( TBW ) and body cell mass (BCM)/A retrosp

496*/21199
33115
42340